Diabetic Foot Ulcers Treatment Market By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers), By Treatment (Wound Care Dressings, Bio-Actives, Wound Care Devices, Antibiotic Medication, Pipeline Analysis) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Diabetic foot ulcers is a type of chronic wound affecting millions of patients across the globe. Diabetic foot ulcers are thickened wounds below the ankle in a diabetic patient irrespective of its duration. On account of high prevalence of diabetes, increasing geriatric population and lack of awareness on preventive measures the global diabetic foot ulcers market shows a lucrative growth between the forecast period 2017 and 2025.

The current report of diabetic foot ulcers treatment market encompasses offers essential market insights and analysis coupled with it market size, pipeline analysis and forecast estimations for the time scale, 2015-2025. This study covers a complete anatomization of the current market and provides current trends and goals of the existing market leaders.

The diabetic foot ulcers treatment market is analyzed by dissecting the market within different segments which are as follows:

  • Ulcer Type
    • Neuropathic Ulcers
    • Ischemic Ulcers
    • Neuro-ischemic Ulcers
  • Treatment
    • Wound Care Dressings
      • Foam Dressings
      • Film Dressings
      • Hydrocolloid Dressings
      • Surgical Dressings
      • Hydrogel Dressings
    • Bio-actives
      • Growth Factors
      • Skin Grafts
      • Others
    • Wound Care Devices
      • Negative Pressure Wound Therapy
      • Ultrasound Therapy
    • Antibiotics Medication
    • Pipeline Analysis
      • WH-1 Ointment
      • Locilex (Pexiganan)
      • VM202
      • Granexin

The outreach of diabetic foot ulcers treatment among various geographies has also been evaluated. In order to carry out this study the diabetic foot ulcers treatment market was segmented as follows:

  • North America
    • U.S
    • Canada
  • Europe
    • U.K
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of MEA

Market share analysis and forecast estimations for the aforementioned segments are provided in terms of US$ Mn for the forecast period, 2017-2025. Furthermore, the respective growth rates for each segment has also been included. These values have been estimated keeping 2016 as its base year.

The factors that affect the growth of the diabetic foot ulcer treatment market such as market drivers, various opportunities existing within the market and market restraints have been incorporated in this study report. Company partnerships, withdrawals and pipeline molecules with target based therapy to treat diabetic foot ulcers are also one of the key inclusions of this report. The key industries holding dominance in the diabetic foot ulcers market have been identified and profiled in terms of their annual sales and growth, current market trends, key products in diabetic foot ulcer treatments, worldwide presence and generic company details. The key players of this market that have been profiled are Coloplast A/S, Medtro nic Plc., Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries, Inc., BSN Medical GMBH, Molnlycke Health Care AB, Acelity L.P. Inc., Organogenesis, Inc., 3M Healthcare, Smith & Nephew Plc., ConvaTec, Inc., Oneness Biotech Co., Ltd., Dipexium Pharmaceuticals, Inc., ViroMed Co., Ltd. & FirstString Research, Inc. A competitive landscape of the aforementioned players pertaining to their market dominance has also been presented in this report.

Diabetic Foot Ulcers Treatment Market

For the purpose of this study, the diabetic foot ulcers treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Diabetic Foot Ulcers Treatment Market

The global diabetic foot ulcers treatment market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Of the aforementioned segments, North America accounts for major share in the diabetic foot ulcers market due to increasing prevalence of diabetes, rising geriatric population, emphasis of development of break through molecules and developed healthcare infrastructure. The Medicare program in the U.S. spends more than US$ 9 billion annually on patients with diabetes-associated lower-extremity wounds, denoting availability of reimbursement policies propelling the growth of this market. Europe lines up second in this market after North America. As per The National Institute for Health and Care Excellence (NICE) the annual cost for treating diabetic foot wounds accounts to £650 million. The rise in prevalence of diabetes, developed healthcare infrastructure and availability reimbursement policies have fueled the European diabetic foot ulcers treatment market. Asia Pacific is expected to grow at a faster rate in this market in during the forecast period of 2017-2025. This growth is attributed to factors such as increasing prevalence of diabetes, development of better healthcare infrastructure and continuous efforts to maintain sustainable healthcare growth by financial inclusions.

Choose License Type
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58842
Report Format:   PDF
Pages:   120
Rating:    4.4 (60)
Connect With Us
24/7 Research Support